Product menu

VISUAL OF A YOUNG FEMALE DOCTOR FACING AN OLDER FEMALE PATIENT

Getting started with AREXVY

Learn about proper reconstitution, administration, and storage information for AREXVY.

Reconstitution and administration

AREXVY is supplied as 2 vials for reconstitution and administered in 1 dose.1

AREXVY must only be reconstituted with the supplied adjuvant suspension.

Each 1-pack (box) of AREXVY contains 2 vials:

IMAGE OF A VIAL AREXVY AS01E

Vial 1: AS01E adjuvant suspension component (liquid, brown cap)

IMAGE OF A VIAL AREXVY IN LYOPHOLIZED FORM

Vial 2: Lyophilized RSVPreF3 antigen component (powder, mustard-coloured cap)

Administer 1 dose (0.5 mL) of AREXVY as an intramuscular injection only, preferably in the deltoid muscle.

RSVPreF3 = recombinant RSV glycoprotein F stabilized in the pre-fusion conformation.

The 2 vials must be combined prior to administration using the 4-step process outlined below.

ICON OF A VIAL UPSIDE DOWN WITH A SYRNINGE PULLING THE MEDICINE OUT

STEP 1: WITHDRAW
Cleanse both vial stoppers. Using a sterile needle and sterile syringe, withdraw the entire contents of the vial containing the adjuvant suspension component (liquid) by slightly tilting the vial. Vial 1 of 2 (brown cap vial).

ICON OF THE SYRINGE DISPENSING ITS ENTIRE CONTENT INTO THE VIAL WITH LYOPHOLIZED POWDER

STEP 2: TRANSFER
Slowly transfer entire contents of syringe into the lyophilized RSVPreF3 antigen component vial (powder). Vial 2 of 2 (mustard-coloured cap vial).

ICON OF GENTLE SWIRLING OF THE VIAL WITH THE SYRINGE STILL IN TACT

STEP 3: SWIRL
Gently swirl the vial until powder is completely dissolved. Do not shake vigorously.

ICON OF A NEW NEEDLE WITHDRAWING THE RECONSTITUDED VACCINE

STEP 4: AFTER RECONSTITUTION
After reconstitution, using a new needle of suitable gauge and length for intramuscular vaccination, withdraw 0.5 mL of the reconstituted vaccine into the syringe, and administer intramuscularly.

See Product Monograph for complete administration instructions.

Use with other vaccines

AREXVY may be given concomitantly with the inactivated quadrivalent seasonal influenza vaccine (standard dose, unadjuvanted). If AREXVY is to be given at the same time as another injectable vaccine, the vaccines should always be administered at different injection sites.

Storage

AREXVY should be refrigerated. DO NOT FREEZE (discard if frozen).

ICON OF MEDICINE BOTTLES SHIELDED FROM SUNLIGHT

Store in the original package to protect from light.

ICON OF THERMOMETER WITH A CELCIUS SYMBOL

Store adjuvant suspension vials and lyophilized antigen vials between 2°C and 8°C before reconstitution.

ICON OF A CLOCK SURPASSING 4 HOURS

After reconstitution, AREXVY should be used promptly; if not possible, the vaccine should be stored in the refrigerator (2–8°C) or at room temperature up to 25°C for up to 4 hours prior to use.

See Product Monograph for complete storage instructions.

ICON OF A PERSON AND A PIECE OF PAPER

Discover AREXVY safety profile

The safety profile of AREXVY in adults aged 60 years and older was evaluated in Study AReSVi-006.1

LEARN MORE

ICON OF A COIN HOVERING OVER A HAND

AREXVY coverage information

Find more information on coverage for the AREXVY vaccine.

LEARN MORE

Reference:

  1. AREXVY Product Monograph. GlaxoSmithKline Inc.

Trademarks are owned by or licensed to the GSK group of companies.

©2024 GSK Group of companies or its licensor.

104605 | 07/24

Open cookie banner
Hide cookie banner